hackettg

/hackettg

About hackettg

This author has not yet filled in any details.
So far hackettg has created 150 blog entries.

MHRA Class 4 Medicines Defect Information: Omeprazole products (Sandoz Limited)

Class 4 Medicines Defect Information: Omeprazole products (Sandoz Limited) Drug alert number: EL (24)A/34 Date issued: 07 August 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Omeprazole products (Sandoz Limited) Company name: Sandoz Limited Product name: Omeprazole 10mg gastro-resistant capsules, PL 04416/0651 SNOMED Code: 3753411000001102 [...]

The post MHRA Class 4 Medicines Defect Information: Omeprazole products (Sandoz Limited) appeared first on Community Pharmacy England.

By |August 7th, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Omeprazole products (Sandoz Limited)

Lagevrio® (molnupiravir) 200 mg hard capsules – shelf life extension

MSD UK in agreement with the Medicines and Healthcare product Regulatory Agency (MHRA) has announced an extension to the shelf-life of of certain batches of Lagevrio® (molnupiravir) 200 mg hard capsules beyond the labelled expiry date by 6, 12 or 18 months. This extension is based on supportive stability data for Lagevrio® which has been [...]

The post Lagevrio® (molnupiravir) 200 mg hard capsules – shelf life extension appeared first on Community Pharmacy England.

By |August 5th, 2024|Lexpos News|Comments Off on Lagevrio® (molnupiravir) 200 mg hard capsules – shelf life extension

MHRA Class 3 Medicines Recall: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd)

Class 3 Medicines Recall: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules (Accord Healthcare Ltd) Drug alert number: EL (24)A/33 MDR number: MDR 113-05/24 Date issued: 30 July 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard [...]

The post MHRA Class 3 Medicines Recall: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd) appeared first on Community Pharmacy England.

By |July 30th, 2024|Lexpos News|Comments Off on MHRA Class 3 Medicines Recall: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd)

Drug Tariff Watch – August 2024

The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 August 2024. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item [...]

The post Drug Tariff Watch – August 2024 appeared first on Community Pharmacy England.

By |July 29th, 2024|Lexpos News|Comments Off on Drug Tariff Watch – August 2024

Expiry of two Clarithromycin SSPs (SSP053 and SSP054)

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Clarithromycin 125mg/5ml and 250mg/5ml oral suspensions are now available to meet normal demand. As a result the Serious Shortage Protocols (SSPs), SSP053 for Clarithromycin 125mg/5ml oral suspension and SSP054 for Clarithromycin 250mg/5ml oral suspension expire at 23.59pm on Friday 19 July 2024. [...]

The post Expiry of two Clarithromycin SSPs (SSP053 and SSP054) appeared first on Community Pharmacy England.

By |July 19th, 2024|Lexpos News|Comments Off on Expiry of two Clarithromycin SSPs (SSP053 and SSP054)